188 related articles for article (PubMed ID: 9160033)
21. Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction.
Jedrzejczak-Czechowicz M; Lewandowska-Polak A; Jarzebska M; Kowalski ML
Allergy Asthma Proc; 2011; 32(1):43-8. PubMed ID: 21262097
[TBL] [Abstract][Full Text] [Related]
22. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G
Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007
[TBL] [Abstract][Full Text] [Related]
23. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Watt GD; Bui TC; Bewtra AK; Townley RG
J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
Nicoară S
Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
[TBL] [Abstract][Full Text] [Related]
25. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
Greiff L; Persson CG; Svensson C; Enander I; Andersson M
J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
[TBL] [Abstract][Full Text] [Related]
26. Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis.
Orfeo V; Vardaro A; Lena P; Mensitieri I; Tracey M; De Marco R
Eur J Ophthalmol; 2002; 12(4):262-6. PubMed ID: 12219994
[TBL] [Abstract][Full Text] [Related]
27. The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model.
Abelson MB; Lanier RQ
Acta Ophthalmol Scand Suppl; 1999; (228):53-6. PubMed ID: 10337434
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
29. A critical look at ocular allergy drugs.
Joseph Titi M
Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
[TBL] [Abstract][Full Text] [Related]
30. The anti-allergic effects of a cromolyn sodium-chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge model.
Leonardi A; Busca F; Tavolato M; Secchi AG
Eur J Ophthalmol; 2003 Mar; 13(2):128-33. PubMed ID: 12696630
[TBL] [Abstract][Full Text] [Related]
31. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
[TBL] [Abstract][Full Text] [Related]
32. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
Abelson MB; Chapin MJ; Kapik BM; Shams NB
Arch Ophthalmol; 2003 May; 121(5):626-30. PubMed ID: 12742839
[TBL] [Abstract][Full Text] [Related]
34. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.
Abelson MB; Spitalny L
Am J Ophthalmol; 1998 Jun; 125(6):797-804. PubMed ID: 9645717
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal eye drops for ocular allergy.
Schwab IR
West J Med; 1994 Dec; 161(6):594-5. PubMed ID: 7856163
[No Abstract] [Full Text] [Related]
37. Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
Takamura E; Nomura K; Fujishima H; Fukagawa K; Satake Y; Fukada Y; Sawa M; Uchida E
Allergol Int; 2006 Jun; 55(2):157-65. PubMed ID: 17075252
[TBL] [Abstract][Full Text] [Related]
38. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG
Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
[TBL] [Abstract][Full Text] [Related]
39. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis.
Akman A; Irkeç M; Orhan M; Erdener U
Ocul Immunol Inflamm; 1998 Sep; 6(3):179-84. PubMed ID: 9785608
[TBL] [Abstract][Full Text] [Related]
40. Tear tryptase in vernal keratoconjunctivitis.
Tabbara KF
Arch Ophthalmol; 2001 Mar; 119(3):338-42. PubMed ID: 11231766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
